Q-linea AB (OSTO:QLINEA) Other Financing: kr-15.92 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:QLINEA Q-linea AB OSTO:QLINEA
65 GF Score
Price kr17.05
GF Value kr19.69
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Q-linea AB Other Financing?

Q-linea AB OSTO:QLINEA -0.29% 65 Other Financing is kr-15.92 Mil as of Jun. 2026. GuruFocus rates OSTO:QLINEA with a GF Score™ of 65/100 and a GF Value™ of kr19.69 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Q-linea AB's Other Financing for the three months ended in Jun. 2026 was kr0.00 Mil.

Q-linea AB's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was kr-15.92 Mil.

Q-linea AB Other Financing Historical Data

* Premium members only.

The historical data trend for Q-linea AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-linea AB Other Financing Chart

Q-linea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.34 0.00 -10.11 -0.58 -41.65

Q-linea AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.01 -0.19 -15.73 0.00 0.00
OSTO:QLINEA
65GF Score
Q-linea AB OSTO:QLINEA
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-linea AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-15.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of kr-15.92 Mil mean?
Q-linea AB (OSTO:QLINEA) has a Other Financing of kr-15.92 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Q-linea AB and its competitors.
Is Q-linea AB's Other Financing too high?
Q-linea AB's current Other Financing is kr-15.92 Mil. Overall, Q-linea AB has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Other Financing compare to ABT and SYK?
Q-linea AB's Other Financing of kr-15.92 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Q-linea AB and its competitors. Q-linea AB's current Other Financing is kr-15.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Based on GuruFocus' analysis, Q-linea AB (OSTO:QLINEA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr19.69, compared to a current price of kr17.05 — trading 13.4% below its estimated fair value. The current Other Financing is kr-15.92 Mil. Q-linea AB's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Q-linea AB (OSTO:QLINEA), the current Other Financing is kr-15.92 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Q-linea AB (OSTO:QLINEA) Overvalued in 2026?

Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued. The current stock price of kr17.05 is trading 13.4% below its estimated GF Value™ of kr19.69. GuruFocus considers Q-linea AB to be Modestly Undervalued.

Key valuation signals for OSTO:QLINEA:

  • Other Financing: kr-15.92 Mil
  • GF Value™: kr19.69 vs. price of kr17.05 (13.4% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the OSTO:QLINEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Q-linea AB Business Description

Other Exchanges 3F80:Germany
Address Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
65GF Score

Get the complete analysis for OSTO:QLINEA

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr17.05
Price
kr19.69
GF Value